Dr. Alok Kanojia (Dr. K)

And furthermore, we're now starting to see things like SSRI withdrawal syndrome.

We're seeing permanent sexual side effects in small cases of antidepressant usage.

We weren't aware of those dangers when we were looking at the original trials.

So my point here is that you have to be really careful

about the safety profile that is found in a clinical trial.

And the key thing is, if you want that safety profile, you need to duplicate the structure of the trial because they're safe when a pharmaceutical person, when like a lab is making a precise milligram amount, which is administered to you, not some crap that you ordered off of the internet or grew in your backyard.

I have never seen a single person who uses psilocybin, even when they grow it, who is measuring the concentration of psilocybin in the magic mushrooms that they're growing in their garage, right?

So the safety profiles that we're seeing from the trials are very different from real world use.

So now we're going to get to two fun things, okay?

Next thing we're going to talk about is microdosing.

So microdosing is like all the fad nowadays.

I've met a ton of people who really love to microdose.

So microdosing is when you take, you know, a small dose of psychedelics.

And this also is where, like, we have to get technical because what is the dose of microdosing, right?

So there's no clear consensus.

So if we're asking, is microdosing effective?

Is it safe?

The question becomes, which psychedelic are we talking about?

And at what dose are we talking about?

I don't hear this level of precision.